Autoantibody detection using multiplex technologies

Lupus

Volumn 15, Issue 7, 2006, Pages 412-421

  Binder, Steven R ^a  

^a BIO RAD LABORATORIES   (United States)

Author keywords

ANA; Autoimmunity; Immunoassays; Multiplex; Protein array

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; POLYSTYRENE; PYROXYLIN; RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOANALYSIS; AUTOMATED PATTERN RECOGNITION; CELIAC DISEASE; CONNECTIVE TISSUE DISEASE; COUNTER IMMUNOELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HYPOTHYROIDISM; IMMUNOASSAY; IMMUNOBLOTTING; LABORATORY TEST; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 33746585779     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2326oa     Document Type: Article

References (94)

1. Wurm M, Epstein FH. Quantitative electrophoresis of serum proteins on paper. Clin Chem 1956; 2: 303-319.
2. Kurata N, Tan EM. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19: 574-580.
3. Habets WJ, de Rooij DJ, Salden MH, et al. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 1983; 54: 265-276.
4. Lerner MR, Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76: 5495-5499.
5. Meilof JF, Bantjes I, De Jong J, Van Dam AP, Smeenk RJ. The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods 1990; 133: 215-226.
6. Jones BR. Lacrimal and salivary precipitating antibodies in Sjögren's syndrome. Lancet 1958; 2: 773-776.
7. Bridges AJ, Lorden TE, Havighurst TC. Autoantibody testing for connective tissue diseases. Comparison of immunodiffusion, immunoblot, and enzyme immunoassay. Am J Clin Pathol 1997; 108: 406-410.
8. Dahle C, Skogh T, Åberg AK, Jalal A, Olcén P. Methods of choice for diagnostic antinuclear antibody (ANA) screening. Benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun 2004; 22: 241-248.
9. Orton SM, Peace-Brewer A, Schmitz JL, Freeman K, Miller WC, Folds JD. Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens. Clin Diagn Lab Immunol 2004; 11: 297-301.
10. Williams DG, Stocks MR, Charles PJ, Maini RN. Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods 1986; 91: 65-73.
11. Dong Q, Ludgate M, Vassart G. Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 72: 1375-1381.
12. Ekins RP. Multi-analyte immunoassay. J Pharm Biomed Anal 1989; 7: 155-168.
13. Ekins R, Chu F, Biggart E. Multispot, multianalyte, immunoassay. Ann Biol Clin (Paris) 1990; 48: 655-666.
14. Silzel JW, Cercek B, Dodson C, Tsay T, Obremski RJ. Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clin Chem 1989; 44: 2036-2043.
15. Donohue J, Balley M, Gray RH et al. Enzyme immunoassay system for panel testing. Clin Chem 1989; 35: 1874-1877.
16. Kakabakos SE, Christopoulos TK, Diamandis EP. Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry. Clin Chem 1992; 38: 338-342.
17. Cambiaso CL, Leek AE, De Steenwinkel F, Billen J, Masson PL. Particle counting immunoassay (PACIA) 1. A general method for the determination of antibodies, antigens, and haptens. J Immunol Methods 1977; 18: 33-44.
18. Collet-Cassart D, Magnusson CGM, Ratcliffe JG, Canbiaso CL, Masson PL. Automated particle-counting immunoassay for alpha-fetoprotein. Clin Chem 1981; 27: 64-67.
19. Bizzaro N, Bonelli F, Tonutti E, Villalta D, Tozzoli R. Autoantibody detection in scleroderma patients. Diagnostic and analytical performances of a new coupled particle light scattering immunoassay. Clin Exp Rheumatol 2002; 20: 45-51.
20. Bizzaro N, Bonelli F, Tonutti E, Tozzoli R, Villalta D. New coupled-particle light-scattering assay for detection of Ro-SSA (52 and 60 Kilodaltons) and La/SSB autoantibodies in connective tissue diseases. Clin Diagn Lab Immunol 2001; 8: 922-925.
21. Streefkerk JG, Kors N, Boden D. Principle of a reaction for simultaneous detection of various antibodies using coloured antigen-coupled agarose beads. In Peeters H ed. Protides of the biological fluids-Proceedings of the twenty-fourth colloquium. Pergamon Press, 1976: 811-814.
22. McHugh TM. Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes. Methods Cell Biol 1994; 42: 575-595.
23. McHugh TM, Wang YJ, Chong HO, Blackwood LL, Stites DP. Development of a microsphere-based fluorescent immunoassay and its comparison to an enzyme immunoassay for the detection of antibodies to three antigen preparations from Candida albicans. J Immunol Methods 1989; 116: 213-219.
24. Stewart MW, Etches WS, Russell AS et al. Detection of antiphospholipid antibodies by flow cytometry: Rapid detection of antibody isotype and phospholipid specificity. Thromb Haemost 1993; 70: 603-607.
25. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR, Jr. Advanced multiplexed analysis with the FlowMetrix™ system. Clin Chem 1997; 43: 1749-1756.
26. Friou GJ. Clinical application of lupus serum-nucleoprotein reaction using the fluorescent antibody technique. J Clin Invest 1957; 36: 890 (abstract).
27. Jaskowski TD, Schroder C, Martins TB, Mouritsen L, Hill HR. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens. J Clin Lab Anal 1995; 9: 166-172.
28. Jitsukawa T, Nakajima S, Usui J, Watanabe H. Detection of anti-nuclear antibodies from patients with systemic rheumatic diseases by ELISA using HEp-2 cell nuclei. J Clin Lab Anal 1991; 5: 49-53.
29. Homburger HA, Cahen YD, Griffiths J, Jacob GL. Detection of antinuclear antibodies. Arch Pathol Lab Med 1998; 122: 993-999.
30. Fenger M, Wiik A, Høier-Madsen M et al. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem 2004; 50: 2141-2147.
31. Wiik AS, Gordon TP, Kavanaugh AF et al. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum 2004; 51: 291-298.
32. Russell AS, Johnston C. Relative value of commercial kits for ANA testing. Clin Exp Rheumatol 2003; 21: 477-480.
33. Keren DF. Antinuclear antibody testing. Clin Lab Med 2002; 22: 447-474.
34. Meheus L, van Venrooij WJ, Wiik A et al. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol 1999; 17: 205-214.
35. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001; 60; 1131-1136.
36. Pottel H, Wiik A, Locht H et al. Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA™ ANA update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol 2004; 22: 579-588.
37. López-Longo FJ, Rodríquez-Mahou M, Escalona-Monge M, González CM, Moteagudo I, Carreño L. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus 2003; 12: 623-629.
38. Hoffman IEA, Peene I, Veys EM, De Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002; 48: 2171-2176.
39. Bossuyt X, Luyckx A. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clin Chem 2005; 51: 2426-2427 (letter).
40. Peene I, Meheus L, De Keyser S, Humbel R, Veys EM, De Keyser F. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis 2002; 61: 929-933.
41. Gordon P, Khamashta MA, Rosenthal E et al. Anti-52 kDa Ro, Anti-60 kDa Ro, and Anti-La antibody profiles in neonatal lupus. J Rheumatol 2004; 31: 2480-2487.
42. Eissfeller P, Sticherling M, Scholz D et al. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Ann NY Acad Sci 2005; 1050: 327-339.
43. Damoiseaux J, Boesten K, Giesen J, Austen J, Cohen Tervaert JW. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann NY Acad Sci 2005; 1050: 340-347.
44. Lochman I, Kloudova A, Lupac J. Comparison of two multiplex assays for anti-ENA/ANA determination. In Conrad K, Sack U eds. Autoantigens, autoantibodies, autoimmunity, Vol. 4. Lengerich, 2004: 471-472.
45. Martins TB, Burlingame R, von Mühlen CA, Jaskowski TD, Litwin CM, Hill HR. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004; 11: 1054-1059.
46. Fritzler MJ. New technologies in the detection of autoantibodies: Evaluation of addressable laser bead immunoassays (ALBIA). In Conrad K, Sack U eds. Autoantigens, autoantibodies, autoimmunity, Vol. 4. Lengerich, 2004; 449-462.
47. Gilburd B, Abu-Shakra M, Shoenfeld Y et al. Autoantibodies profile in the sera of patients with Sjögren's Syndrome: the ANA evaluation-a homogeneous, multiplexed system. Clin Dev Immunol 2004; 11: 53-56.
48. Shovman O, Gilburd B, Zandman-Goddard G, Yehiely A, Langevitz P, Shoenfeld Y. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005; 38: 105-109.
49. Zandman-Goddard G, Gilburd B, Shovman O et al. The homogeneous multiplexed system-a new method for autoantibody profile in systemic lupus erythematosis. Clin Dev Immunol 2005; 12: 107-111.
50. Rouquette A-M, Desgruelles C, Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Path 2003; 120: 676-681.
51. Buliard A, Fortenfant F, Ghillani-Dalbin P, Musset L, Oksman F, Olsson NO. Analysis of nine autoantibodies associated with systemic autoimmune diseases using the Luminex technology. Results of a multicenter study. Ann Biol Clin (Paris) 2005; 63: 51-58.
52. Klutts JS, Liao RS, Dunne WM, Gronowski AM. Evaluation of a multiplexed bead assay for assessment of epstein-Barr virus. J Clin Microbiol 2004; 42: 4996-5000.
53. Shovman O, Gilburd B, Barzilai O et al. Analysis of 510 healthy subjects: Incidence of natural/predictive autoantibodies. Ann NY Acad Sci 2005; 1050: 380-388.
54. Prestigiacomo T, Humbel RL, Larida B, Binder SR. Multiplexed analysis of thirteen antibodies using the BioPlex™ 2200 fully automated immunoassay analyzer. Autoantigens, autoantibodies. In Conrad K, Sack U eds. Autoantigens, autoantibodies, autoimmunity, Vol. 4. Lengerich, 2004, 463-468.
55. Binder SR, Genovese MC, Merrill JT, Morris RI, Metzger AL. Computer-assisted pattern recognition of autoantibody results. Clin Diagn Lab Immunol 2005; 12: 1353-1357.
56. Kavanaugh A. The utility of immunologic laboratory tests in patients with rheumatic diseases. Arthritis Rheum 2001; 44: 2221-2223.
57. Moder KG, Homburger HA, Wener MH, Buckeridge D, Weisman MH, Wallace DJ. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multi-center clinical evaluation (unpublished data).
58. Smith J, Onley D, Garey C et al. Determination of ANA specificity using the Ultraplex™ platform. Ann NY Acad Sci 2005; 1050: 286-294.
59. Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C. A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Methods 2005; 302: 1-12.
60. Phan TG, Wong RCW, Adelstein S. Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin Diagn Lab Immunol 2002; 9: 1-7.
61. Tozzoli R, Bizzaro N, Tonutti E et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117: 316-324.
62. Soloman DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthiritis Rheum 2002; 47: 434-344.
63. Reisner BS, DiBlasi J, Goel N. Comparison of an enzyme immunoassay to an indirect fluorescent immunoassay for the detection of antinuclear antibodies. Am J Clin Pathol 1999; 111: 503-506.
64. González C, García-Berrocal B, Pérez M, Navajo JA, Herraez O, González-Buitrago JM. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically denned patients. Clin Chim Acta 2005; 359: 109-114.
65. Gniewek RA, Stites DP, McHugh TM, Hilton JF, Nakagawa M. Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol 1997; 4: 185-188.
66. Fritzler MJ, Wiik A, Tan EM et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol 2003; 30: 2374-2381.
67. Binder SR, Hixson C, Glossenger J. Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease. Autoimmun Rev 2006; 5: 234-241.
68. Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 2004; 43: 220-224.
69. Merrill JT, Buyon JP. The role of biomarkers in the assessment of lupus. Best Pract Res Clin Rheumatol 2005; 19: 709-726.
70. D'haeseleer P. How does gene expression clustering work? Nat Biotechnol 2005; 23: 1499-1501.
71. Tápanes FJ, Vásquez M, Ramirez R, Matheus C, Rodriguez MA, Bianco N. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? Lupus 2000; 9: 437-444.
72. Hoffman IEA, Peene I, Meheus L et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1155-1158.
73. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis & Rheumatism 2005; 52: 4003-4010.
74. Martins TB. Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin Diagn Lab Immunol 2002; 9: 41-45.
75. Kricka L, Master SR. Validation and quality control of protein microarray-based analytical methods. Methods Mol Med 2005; 144: 233-255.
76. Sharp GC, Irvin WS, LaRoque RL et al. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 1971; 50: 350-359.
77. Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasion and Asian patients. Br J Rheumatol 1997; 36: 229-233.
78. Faria AC, Barcellos KSA, Andrade EC. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol 2005; 32: 1267-1272.
79. Sanmarco M. Contribution of the BioPlex 2200™ in the exploration and the follow-up of patients with systemic lupus erythematosus (unpublished data).
80. Tan EM, Smolen JS, McDougal JS, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 2002; 29: 68-74.
81. Scofield RH. Autoantibodies as predictors of disease. Lancet 2004; 363: 1544-1546.
82. Lyons R, Narain S, Nichols C, Satoh M, Reeves WH. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann NY Acad Sci 2005; 1050: 217-228.
83. Damoiseaux JGMC, Cohen Tervaert JW. From ANA to ENA: How to proceed? Autoimmun Rev 2006; 5: 10-17.
84. Wiik AS. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005; 34: 260-268.
85. Bernardini S, Infantino M, Bellincampi L et al. Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified of recombinant antigens and immunofluorescence assay. Clin Chem Lab Med 2004; 42: 1155-1160.
86. Nossent H, Rekvig OP. Antinuclear antibody screening in this new millennium: farewell to the microscope? Scand J Rheumatol 2001; 30: 123-126.
87. Tonutti E, Bassetti D, Piazza A et al. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 2004; 37: 171-176.
88. González C, García-Berrocal B, Talaván T, Casas ML, Navajo JA, González-Buitrago JM. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem 2005; 38: 966-972.
89. Yiannaki E, Zintzaras E, Analatos A, Theodoridou C, Dalekos G, Germenis AE. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease. J Immunoassay Immunochem 2004; 25: 345-357.
90. Prestigiacomo T, Watkins M, Binder SR, Homburger H. Evaluation of a multiplexed MPO, PR3 and GBM immunoassay on the Bio-Rad BioPlex™ 2200. Clin Chem 2005; 51 (Suppl): A77 (abstract B-87).
91. Drouvalakis KA, Neeson PJ, Buchanan RR. Detection of anti- phosphatidylethanolamine antibodies using flow cytometry. Cytometry 1999; 36: 46-51.
92. Binder SR, Tan W, Prestigiacomo A. Performance of a multiplexed immunoassay for cardiolipin, phosphatidylserine and B2GPI IgG antibodies. Immunobiology; 2005; 209 (Suppl S1): 45-46 (abstract 1734).
93. González-Buitrago JM, González C. Present and future of the autoimmunity laboratory. Clin Chim Acta 2006; 365: 50-57.
94. Price CP. Microarrays: the reincarnation of multiplexing in laboratory medicine, but now more relevant? Clin Chem 2001; 47: 1345-1346.